Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Change in Acquisitions & Divestments: 2015-2025

Historic Change in Acquisitions & Divestments for ImmunityBio (IBRX) over the last 8 years, with Mar 2025 value amounting to $5.3 million.

  • ImmunityBio's Change in Acquisitions & Divestments fell 58.91% to $5.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $107.9 million, marking a year-over-year increase of 184.92%. This contributed to the annual value of $115.6 million for FY2024, which is 1044.42% up from last year.
  • Per ImmunityBio's latest filing, its Change in Acquisitions & Divestments stood at $5.3 million for Q1 2025, which was down 70.33% from $18.0 million recorded in Q4 2024.
  • In the past 5 years, ImmunityBio's Change in Acquisitions & Divestments ranged from a high of $99.1 million in Q2 2022 and a low of $102,000 during Q1 2023.
  • Over the past 3 years, ImmunityBio's median Change in Acquisitions & Divestments value was $13.0 million (recorded in 2024), while the average stood at $18.7 million.
  • As far as peak fluctuations go, ImmunityBio's Change in Acquisitions & Divestments crashed by 99.29% in 2023, and later spiked by 12,665.69% in 2024.
  • Quarterly analysis of 5 years shows ImmunityBio's Change in Acquisitions & Divestments stood at $11.4 million in 2021, then soared by 2,359.00% to $14.8 million in 2022, then slumped by 99.29% to $10.0 million in 2023, then surged by 80.38% to $18.0 million in 2024, then tumbled by 58.91% to $5.3 million in 2025.
  • Its Change in Acquisitions & Divestments was $5.3 million in Q1 2025, compared to $18.0 million in Q4 2024 and $49.5 million in Q3 2024.